Distinguishing externally from saccade-induced motion in visual cortex

por Miura, Satoru K., Scanziani, Massimo
Publicado 2022

Publisher Correction: Distinguishing externally from saccade-induced motion in visual cortex

por Miura, Satoru K., Scanziani, Massimo
Publicado 2022

Efficient sampling of shiitake-inoculated oak logs to determine the log-to-mushroom transfer factor of stable cesium

por O’Brien, Martin, Hiraide, Masakazu, Ohmae, Yoshimi, Nihei, Naoto, Miura, Satoru, Tanoi, Keitaro
Publicado 2019

Real‐world therapeutic effectiveness of lorlatinib after alectinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer

por Goto, Yasushi, Shukuya, Takehito, Murata, Ai, Kikkawa, Hironori, Emir, Birol, Wiltshire, Robin, Miura, Satoru
Publicado 2023

Promotion of Behavioral Change and the Impact on Quality of Life in Elderly Patients with Advanced Cancer: A Physical Activity Intervention of the Multimodal Nutrition and Exercise...

por Mouri, Takako, Naito, Tateaki, Morikawa, Ayumu, Tatematsu, Noriatsu, Miura, Satoru, Okayama, Taro, Omae, Katsuhiro, Takayama, Koichi
Publicado 2018

Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer?

por Ikeda, Satoshi, Naito, Tateaki, Miura, Satoru, Ito, Kentaro, Furuya, Naoki, Misumi, Toshihiro, Ogura, Takashi, Kato, Terufumi
Publicado 2022

Lung squamous cell carcinoma with rare epidermal growth factor receptor mutation G719X: a case report and literature review

por Bi, Huanhuan, Ren, Dunqiang, Wu, Jieqiong, Ding, Xiaoqian, Guo, Caihong, Miura, Satoru, Megyesfalvi, Zsolt, Arulananda, Surein, Wang, Hongmei
Publicado 2021

DDX3X Induces Primary EGFR-TKI Resistance Based on Intratumor Heterogeneity in Lung Cancer Cells Harboring EGFR-Activating Mutations

por Nozaki, Koichiro, Kagamu, Hiroshi, Shoji, Satoshi, Igarashi, Natsue, Ohtsubo, Aya, Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Yoshizawa, Hirohisa, Narita, Ichiei
Publicado 2014

Randomized, open-label phase II study of brigatinib and carboplatin plus pemetrexed and brigatinib alone for chemotherapy-naive patients with ALK-rearranged non-squamous non-small...

por Wakuda, Kazushige, Kenmotsu, Hirotsugu, Sato, Yuki, Nakamura, Atsushi, Akamatsu, Hiroaki, Tachihara, Motoko, Miura, Satoru, Yokoyama, Toshihide, Mori, Keita, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki
Publicado 2023

Afatinib for the Treatment of Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: An Updated Database of 1023 Cases Brief Report

por Yang, James Chih-Hsin, Schuler, Martin, Popat, Sanjay, Miura, Satoru, Park, Keunchil, Passaro, Antonio, De Marinis, Filippo, Solca, Flavio, Märten, Angela, Kim, Edward S.
Publicado 2022

Immune thrombocytopenia in a small cell lung cancer patient treated with atezolizumab: a case report

por Qiu, Guihuan, Li, Suyang, Li, Bingliang, Yang, Qingqing, Deng, Haiyi, Yang, Yilin, Xie, Xiaohong, Lin, Xinqing, Seki, Nobuhiko, Miura, Satoru, Shukuya, Takehito, Zhou, Chengzhi, Liu, Ming
Publicado 2022

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 14...

por Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Tanaka, Hiroshi, Ito, Kazuhiko, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Matsumoto, Naoya, Sato, Kazuhiro, Ichikawa, Kosuke, Abe, Tetsuya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki
Publicado 2021

Prognostic significance of procalcitonin in small cell lung cancer

por Ichikawa, Kosuke, Watanabe, Satoshi, Miura, Satoru, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Tanaka, Tomohiro, Saida, Yu, Kondo, Rie, Hokari, Satoshi, Aoki, Nobumasa, Ohshima, Yasuyoshi, Koya, Toshiyuki, Kikuchi, Toshiaki
Publicado 2022

Correlation of prechemotherapy urinary megalin ectodomain (A-megalin) levels with the development of cisplatin-induced nephrotoxicity: a prospective observational study

por Shoji, Satoshi, Hosojima, Michihiro, Kabasawa, Hideyuki, Kondo, Rie, Miura, Satoru, Watanabe, Satoshi, Aoki, Nobumasa, Kaseda, Ryohei, Kuwahara, Shoji, Tanabe, Naohito, Hirayama, Yoshiaki, Narita, Ichiei, Kikuchi, Toshiaki, Kagamu, Hiroshi, Saito, Akihiko
Publicado 2019

Afatinib plus osimertinib in the treatment of osimertinib-resistant non-small cell lung carcinoma: a phase I clinical trial

por Miura, Satoru, Koh, Yasuhiro, Azuma, Koichi, Yoshioka, Hiroshige, Koyama, Kenichi, Teraoka, Shunsuke, Ishii, Hidenobu, Kibata, Kayoko, Ozawa, Yuichi, Tokito, Takaaki, Oyanagi, Jun, Shimokawa, Toshio, Kurata, Takayasu, Yamamoto, Nobuyuki, Tanaka, Hiroshi
Publicado 2023

Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional...

por Miura, Satoru, Jung, Hyun Ae, Lee, Shin Yup, Lee, Seung Hyeun, Lee, Min Ki, Lee, Yong Chul, Hochmair, Maximilian J, Yang, Cheng-Ta, Märten, Angela, Yang, James Chih-Hsin, Popat, Sanjay
Publicado 2022

Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors

por Sato, Ko, Watanabe, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Ishikawa, Daisuke, Tanaka, Tomohiro, Nozaki, Koichiro, Kondo, Rie, Okajima, Masaaki, Miura, Satoru, Tanaka, Junta, Sakagami, Takuro, Koya, Toshiyuki, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Narita, Ichiei
Publicado 2016

A phase II study of Osimertinib for patients with radiotherapy-naïve CNS metastasis of non-small cell lung cancer: treatment rationale and protocol design of the OCEAN study (LOGIK...

por Wakuda, Kazushige, Yamaguchi, Hiroyuki, Kenmotsu, Hirotsugu, Fukuda, Minoru, Takeshita, Masafumi, Suetsugu, Takayuki, Kirita, Keisuke, Ebi, Noriyuki, Hataji, Osamu, Miura, Satoru, Chibana, Kenji, Okamoto, Isamu, Yoshimura, Kenichi, Nakagawa, Kazuhiko, Yamamoto, Nobuyuki, Sugio, Kenji
Publicado 2020

Nivolumab Retreatment in Non–Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L)

por Akamatsu, Hiroaki, Teraoka, Shunsuke, Takamori, Shinkichi, Miura, Satoru, Hayashi, Hidetoshi, Hata, Akito, Toi, Yukihiro, Shiraishi, Yoshimasa, Mamesaya, Nobuaki, Sato, Yuki, Furuya, Naoki, Oyanagi, Jun, Koh, Yasuhiro, Misumi, Toshihiro, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2022

Docetaxel Plus Ramucirumab With Primary Prophylactic Pegylated Granulocyte-Colony Stimulating Factor Support for Elderly Patients With Advanced NSCLC: A Multicenter Prospective Sin...

por Tachihara, Motoko, Hata, Akito, Tokito, Takaaki, Hara, Satoshi, Okada, Hideaki, Miura, Satoru, Sato, Yuki, Tabata, Eriko, Watanabe, Hiroshi, Takayama, Yusuke, Toyozawa, Ryo, Ota, Keiichi, Wakuda, Kazushige, Nakamura, Atsushi, Shimokawa, Mototsugu, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Publicado 2023